Scientific Program

  • September 9 (THU)
  • September 10 (FRI)
09:00-09:10 Opening Ceremony
Symposium 1
09:10 - 11:10 Public health response to COVID-19 Chair : Dennis Dixon (USA),
Kyong Ran Peck (Korea)
S1-1 Public health response to COVID-19: National perspective
Hsien-Ho Lin ( National Taiwan University ), Taiwan
S1-2 Public health response to COVID-19: Regional perspective
Sharon Salmon ( World Health Organization ), Philippines
S1-3 Public health response to COVID-19: Global perspective
Maria Van Kerkhove ( WHO ), Switzerland
S1-4 Strategies to flatten the curve: current evidence and practical pitfalls
Paul Ananth Tambyah ( National University of Singapore ), Singapore
Symposium 2
09:10 - 11:10 Gram-negative bacteria Chair : David Paterson (Australia),
Mi-Na Kim (Korea)
S2-1 Epidemiology and impact of carbapenem-resistant Acinetobacter and Pseudomonas
Po-Ren Hsueh ( China Medical University, China Medical University Hospital ), Taiwan
S2-2 Epidemiology and impact of carbapenem-resistant Enterobacteriaceae
Anucha Apisarnthanarak ( Thammasat University Hospital ), Thailand
S2-3 Emergence of intrinsic resistant Gram-negative bacteria with an environmental primary habitat
José Luis Martínez ( Centro Nacional de Biotecnología. CSIC ), Spain
S2-4 Antimicrobial therapy for carbapenem-resistant gram-negative bacteria
Yohei Doi ( University of Pittsburgh ), USA
Symposium 3
09:10 - 11:10 How I treat difficult-to-treat infections (interactive) Chair : Jae-Hoon Song (Korea),
Eun Hwa Choi (Korea)
S3-1 How I treat persistent S. aureus bacteremia
Vance Fowler ( Duke Department of Medicine ), USA
S3-2 How I treat vascular graft infections
M. Rizwan Sohail ( Baylor College of Medicine ), USA
S3-3 How I treat CMV infection in high-risk pediatric patients?
Yae-Jean Kim ( Samsung Medical Center ), Korea
Plenary Lecture 1
11:10 - 11:50 Chair : Dennis Dixon (USA)
P-1 Role of National Centre for Infectious Diseases during COVID-19
Yee Sin Leo ( National Centre for Infectious Diseases ), Singapore
Plenary Lecture 2
11:50 - 12:30 Chair : Victor Lim (Malaysia)
P-2 Vaccines against SARS-CoV-2
Jerome H. Kim ( International Vaccine Institute ), Korea
Plenary Lecture 3
15:10 - 15:50 Chair : Jae-Hoon Song (Korea)
P-3 Overview of the current status of antimicrobial resistance
David Livermore ( University of East Anglia ), UK
Symposium 4
15:50 - 17:20 Clinical management of COVID-19 Chair : Min Ja Kim (Korea)
Shin-Woo Kim (Korea)
S4-1 Therapeutic options for COVID-19
Davey Smith ( University of California San Diego ), USA
S4-2 Therapeutics for COVID-19
Yaseen Arabi ( King Abdulaziz Medical City, Ministry of National Guard Health Affairs ), Kingdom of Saudi Arabia
S4-3 Long-term sequelae of COVID-19
Bin Cao ( National Clinical Research Center for Respiratory Diseases ), PR China
Symposium 5
15:50 - 17:20 Diagnostics/clinical microbiology Chair : David Livermore (UK),
Mi-Na Kim (Korea)
S5-1 The future is here: rapid diagnosis of antimicrobial resistance
Robin Patel ( Mayo Clinic ), USA
S5-2 Next-generation sequencing for diagnosing infectious diseases
John W. A. Rossen (Department of Medical Microbiology and Infection Prevention, University of Groningen), The Netherlands
S5-3 How to combine novel techniques with stewardship: a real-world experience
Tristan Timbrook, PharmD (bioMérieux; The University of Utah ), USA
Symposium 6
15:50 - 17:20 Antimicrobial stewardship Chair : Yee-Sin Leo (Singapore),
Sungmin Kim (Korea)
S6-1 Shorter the better: current evidence for the shorter duration of antibiotic therapy
David Paterson ( University of Queensland ), Australia
S6-2 Capacity for antimicrobial stewardship in the Asia Pacific
David Lye ( Tan Tock Seng Hospital ), Singapore
S6-3 Antimicrobial stewardship during the COVID-19 pandemic
Timothy Miles Rawson ( Imperial College London ), UK
Symposium 7
09:00 - 11:00 Pros and cons (interactive) Chair : Anucha Apisarnthanarak (Thailand),
Hyunjoo Pai (Korea)
S7-1 Early oral transition for endocarditis
Pro) Jose M. Miro ( Hospital Clínic of Barcelona ), Spain
Con) Vance Fowler ( Duke Department of Medicine ), USA
S7-2 Piperacillin-tazobactam for ESBL-producing Enterobacterales
Pro) Jesús Rodríguez-Baño ( Hospital Universitario Virgen Macarena ), Spain
Con) Patrick Harris ( The University of Queensland ), Australia
S7-3 Combination regimen for carbapenem-resistant Acinetobacter infections
Pro) Andrea L. Kwa ( Singapore General Hospital ), Singapore
Con) Visanu Thamlikitkul ( Mahidol University), Thailand
Symposium 8
09:00 - 11:00 Gram-positive bacteria Chair : Paul Ananth Tambyah (Singapore),
Yang Soo Kim (Korea)
S8-1 Update on antimicrobial resistance of Staphylococcus
Michael Otto ( National Institute of Allergy and Infectious Diseases ), USA
S8-2 Genomic insights into vancomycin-resistant Enterococcus faecium
Glen Carter ( The University of Melbourne ), Australia
S8-3 How to dose vancomycin: time to go Bayesian?
Jennifer Le ( University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences ), USA
S8-4 Novel therapeutic approaches to bacterial infection
Andrew M. Edwards ( Imperial College London ), UK
Symposium 9
09:00 - 11:00 Infection prevention and control Chair : Cheng-Hsun Chiu ( Taiwan ),
Woo Joo Kim ( Korea )
S9-1 Indoor transmission of SARS-CoV-2
Hua Qian ( Southeast University, China ), PR China
S9-2 Infection control for COVID-19: theory and practice
Kalisvar Marimuthu ( National Centre for Infectious Diseases ), Singapore
S9-3 Environmental cleaning & disinfection: current controversies
Stephan Harbarth ( Geneva University Hospital ), Switzerland
S9-4 Outbreak control in healthcare settings
Doo Ryeon Chung ( Samsung Medical Center ), Korea
Plenary Lecture 4
11:10 - 11:50 Chair : Vance Fowler (USA)
P-4 The Trifecta of Diagnostic Stewardship, Antimicrobial Stewardship, and Value Assessment of New Diagnostic Tests
Robin Patel ( Mayo Clinic ), USA
Plenary Lecture 5
11:50 - 12:30 Chair : Robin Patel (USA)
P-5 Promoting the development of novel therapeutic agents
Dennis M. Dixon ( National Institute of Allergy and Infectious Diseases ), USA
Plenary Lecture 6
15:10 - 15:50 Chair : Po-Ren Hsueh (Taiwan)
P-6 Designing and conducting clinical trials that change the practice
David Paterson ( University of Queensland ), Australia
Symposium 10
15:50 - 17:20 Fungus Chair : Jun Hee Woo (Korea),
Jong Hee Shin (Korea)
S10-1 Epidemiology and impact of anti-fungal resistance in Asia
Ban Hock Tan ( Singapore General Hospital ), Singapore
S10-2 The confluence between viral and fungal infections
Monica Slavin ( Peter MacCallum Cancer Centre ), Australia
S10-3 Novel therapeutic options for invasive fungal infections
David W. Denning ( The University of Manchester and Global Action Fund for Fungal Infections ), UK
Symposium 11
15:50 - 17:20 Vaccine Chair : Kang Won Choe (Korea), Hee Jin Cheong (Korea)
S11-1 Future role of vaccines on antibacterial resistance
Paul Ananth Tambyah ( National University of Singapore ), Singapore
S11-2 Novel technologies for vaccine development
Kaitlyn M. Morabito ( DMID, NIAID, NIH ), USA
S11-3 What we learned from COVID-19 vaccination
Eui-Cheol Shin ( Korea Advanced Institute of Science and Technology ), Korea
Symposium 12
15:50 - 17:20 HIV Chair : Davey Smith (USA),
Sang Il Kim (Korea)
S12-1 Current Strategies for Antiretroviral Therapy
Roy M. Gulick ( Weill Cornell Medicine ), USA
S12-2 PrEP and disparities in access in the Asia Pacific
Shui Shan Lee ( The Chinese University of Hong Kong ), Hong Kong, China